Bruce Booth, an insider at Kymera Therapeutics, Inc. (KYMR), divested 231,007 shares of the company's stock on June 30, 2026. The transactions occurred at an average price of $108.14 per share, representing a total value of approximately $24.98 million.
This sale follows other recent insider selling activity within Kymera Therapeutics. On July 1, 2026, Nello Mainolfi sold a total of 98,117 shares across multiple transactions, amounting to over $9.2 million. Additionally, Noah Goodman sold 3,389 shares for approximately $387,328 on the same day.
Insider sales can be driven by various factors including portfolio diversification, tax obligations, or pre-arranged trading plans and do not necessarily reflect a negative outlook on the company's future performance.